Challenges and opportunities in using telehealth for diabetes care SS Crossen, BS Bruggeman, MJ Haller, JK Raymond Diabetes Spectrum: a Publication of the American Diabetes Association 35 (1), 33, 2022 | 31 | 2022 |
Exocrine pancreas dysfunction in type 1 diabetes TP Foster, B Bruggeman, M Campbell-Thompson, MA Atkinson, MJ Haller, ... Endocrine Practice 26 (12), 1505-1513, 2020 | 26 | 2020 |
Addressing health disparities in type 1 diabetes through peer mentorship AF Walker, MJ Haller, MJ Gurka, HL Morris, B Bruggeman, K Miller, ... Pediatric diabetes 21 (1), 120-127, 2020 | 25 | 2020 |
Simple tests of cardiorespiratory fitness in a pediatric population BS Bruggeman, HK Vincent, X Chi, SL Filipp, R Mercado, F Modave, ... PLoS One 15 (9), e0238863, 2020 | 20 | 2020 |
Characterising the age-dependent effects of risk factors on type 1 diabetes progression M So, C O’Rourke, A Ylescupidez, HT Bahnson, AK Steck, JM Wentworth, ... Diabetologia 65 (4), 684-694, 2022 | 14 | 2022 |
Low-dose ATG/GCSF in established type 1 diabetes: a five-year follow-up report A Lin, JA Mack, B Bruggeman, LM Jacobsen, AL Posgai, CH Wasserfall, ... Diabetes 70 (5), 1123-1129, 2021 | 13 | 2021 |
Thyroid storm caused by hyperemesis gravidarum CF Zimmerman, AB Ilstad-Minnihan, BS Bruggeman, BJ Bruggeman, ... AACE Clinical Case Reports 8 (3), 124-127, 2022 | 11 | 2022 |
Barriers to retinopathy screening in youth and young adults with type 1 diabetes B Bruggeman, C Zimmerman, A LaPorte, M Stalvey, SL Filipp, MJ Gurka, ... Pediatric Diabetes 22 (3), 469-473, 2021 | 5 | 2021 |
Substance use affects type 1 diabetes pancreas pathology: implications for future studies BS Bruggeman, M Campbell-Thompson, SL Filipp, MJ Gurka, ... Frontiers in endocrinology 12, 778912, 2021 | 4 | 2021 |
Low-Dose Antithymocyte Globulin: A Pragmatic Approach to Treating Stage 2 Type 1 Diabetes TP Foster, LM Jacobsen, B Bruggeman, C Salmon, J Hosford, A Chen, ... Diabetes Care 47 (2), 285-289, 2024 | 2 | 2024 |
The ISPAD Clinical Practice Consensus Guidelines 2022: how far we have come and the distance still to go BS Bruggeman, DA Schatz The Lancet Diabetes & Endocrinology 11 (5), 304-307, 2023 | 2 | 2023 |
An iterative process for identifying pediatric patients with type 1 diabetes: retrospective observational study HL Morris, WT Donahoo, B Bruggeman, C Zimmerman, P Hiers, ... JMIR Medical Informatics 8 (9), e18874, 2020 | 1 | 2020 |
A content analysis of text messages in a type 1 diabetes peer mentoring program—the importance of shared interests AF Walker, C Johnson, C Anez-Zabala, SR Dorvil, MJ Haller, MJ Gurka, ... Diabetes 67 (Supplement_1), 2018 | 1 | 2018 |
1622-P: Congruence of Laboratory vs. Histopathologic Findings of Acute Pancreatitis within nPOD Organ Donors J PENA LOPEZ, M CAMPBELL-THOMPSON, BS BRUGGEMAN Diabetes 73 (Supplement_1), 2024 | | 2024 |
1205-P: Exocrine Function in Individuals at High Risk for Type 1 Diabetes K MORNEAULT-GILL, M GUYOT, J GESTON, C GEORGAS, ... Diabetes 73 (Supplement_1), 2024 | | 2024 |
1623-P: Artificial Intelligence with QuPATH in Pancreatic Cell Classification M GUYOT, MD WILLIAMS, BM BUMGARNER, KM MCGRAIL, ... Diabetes 73 (Supplement_1), 2024 | | 2024 |
Multicenter Evaluation of Ultra-Rapid Lispro Insulin with Control-IQ Technology in Adults, Adolescents, and Children with Type 1 Diabetes CJ Levy, R Bailey, LM Laffel, G Forlenza, LA DiMeglio, MS Hughes, ... Diabetes Technology & Therapeutics, 2024 | | 2024 |
Blue Circle Health: A Novel Patient-Centered Model of Health Care Delivery for Low-Income Patients With Type 1 Diabetes BS Bruggeman, AF Walker, AL Peters, LW D’Avolio, MJ Haller Journal of Diabetes Science and Technology 17 (4), 925-934, 2023 | | 2023 |
Type 1 Diabetes: A Disorder of the Exocrine and Endocrine Pancreas BS Bruggeman, DA Schatz Journal of cellular immunology 5 (4), 120, 2023 | | 2023 |
Serum exocrine enzymes as biomarkers of response to immunotherapy in type 1 diabetes. B Bruggeman, K McGrail, N Gonzalez, C Wasserfall, ... HORMONE RESEARCH IN PAEDIATRICS 95 (SUPPL 1), 58-59, 2022 | | 2022 |